Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Mar. 19, 2019– Urovant Sci...
read more
Burnout research: Overactive immune system the cause of chronic fatigue syndrome

Burnout research: Overactive immune system the cause of chronic fatigue syndrome

Experts find cause of chronic fatigue syndrome The...
read more